Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
286-300 of 400
Evolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
On the Frontlines of Prostate CancerEvolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
Daniel J. George, MD
Advancing Patient-Centered Care in HER2-Positive Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerAdvancing Patient-Centered Care in HER2-Positive Metastatic Breast Cancer
Megan Kruse, MD
Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Project Oncology®Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Optimizing Quality of Life in HER2+ Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerOptimizing Quality of Life in HER2+ Metastatic Breast Cancer
Megan Kruse, MD
Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
Living RheumRecognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
Laura Cappelli, MD, MHS,MS
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
Clinician's RoundtableProstate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
Ihtisham Ahmad
- advertisement
Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Project Oncology®Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Balancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
On the Frontlines of Metastatic Breast CancerBalancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
Paolo Tarantino, MD
Navigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
On the Frontlines of Metastatic Breast CancerNavigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
Paolo Tarantino, MD
Reducing Prostate Cancer Cell Production: The Role of Bipolar Androgen Therapy
On the Frontlines of Prostate CancerReducing Prostate Cancer Cell Production: The Role of Bipolar Androgen Therapy
Mohit Khera, M.D., M.B.A., M.P.H.
Reducing Patient Time Burden in HER2+ Breast Cancer with Subcutaneous Trastuzumab/Pertuzumab
Project Oncology®Reducing Patient Time Burden in HER2+ Breast Cancer with Subcutaneous Trastuzumab/Pertuzumab
Reevaluating Testosterone: A Paradigm Shift in Prostate Cancer Treatment
On the Frontlines of Prostate CancerReevaluating Testosterone: A Paradigm Shift in Prostate Cancer Treatment
Mohit Khera, M.D., M.B.A., M.P.H.
- advertisement
Prostate Cancer Care: Testosterone Therapy’s Impact on Biochemical Recurrence
On the Frontlines of Prostate CancerProstate Cancer Care: Testosterone Therapy’s Impact on Biochemical Recurrence
Mohit Khera, M.D., M.B.A., M.P.H.
Slowing Prostate Cancer Progression: The Role of Dietary Fat Modifications
On the Frontlines of Prostate CancerSlowing Prostate Cancer Progression: The Role of Dietary Fat Modifications
William Aronson, MD
Early-Stage Prostate Cancer Treatment: Examining Long-Term Complications
On the Frontlines of Prostate CancerEarly-Stage Prostate Cancer Treatment: Examining Long-Term Complications
Joseph Unger, PhD, MS
